![]() |
Rho Chi Post Interview with Dean Mangione...
May 1, 2012 - Featured , Professional Advice / Opinions By: Mohamed Dungersi & Mahdieh Danesh Yazdi, Associate Student Editors – Each month, the editors at the Rho Chi Post have the opportunity to interview one or more of our faculty members. This month, we had the tremendous opportunity to interview the dean of St. John’s University College of Pharmacy and Allied Health Professions, Dean… |
![]() |
A Reflection of a First-Year Pharmacy Student...
May 1, 2012 - Professional Advice / Opinions By: Sylva Ohanian, Pharm.D. Candidate c/o 2017 – Finally, I understood the hype. Impatience rendered my heart anew as I rushed into an epiphany 1,353 feet above Chicago. The Skydeck was flooded with tourists and natives alike, continuously breaking record-numbers in visitors. Why do they continue to come en masse here? Is it the… |
![]() |
Rho Chi Executive Board Member Insight: Aleena Cherian...
May 1, 2012 - Professional Advice / Opinions By: Mohammad A. Rattu, Pharm.D. Candidate c/o 2012 – We sometimes need to step back and look at our foundations for success. Clearly, without the support of past and present Rho Chi executive boards, there would be no Rho Chi Post newsletter. Over the next five issues, we will learn about each of our… |
![]() |
Role of Calcium Channel Blockers and Beta Blockers in C...
May 1, 2012 - Clinical , Featured By: Lunbao Huang Pharm D. Candidate c/o 2013 – The seventh report of the Joint National Committee on high blood pressure (JNC-7) states that most classes of antihypertensive drugs such as angiotensin converting enzyme inhibitors (ACEIs), angiotensin-II receptor blockers (ARBs), beta-blockers (BBs), diuretics, and aldosterone-receptor antagonists can be used for hypertensive heart failure patients except… |
![]() |
Lipid Panels: Fasting or Non-Fasting?...
April 1, 2012 - Clinical By: Nagma Gargi, Pharm D. Candidate 2013 – Traditionally, lipid panels are drawn under fasting conditions. Is there data supporting decreased accuracy in a non-fasting lipid panel? Cholesterol is an essential tool for our body for the synthesis of hormones, vitamin D, and bile acids. However, an excess of cholesterol pose a serious threat to… |
![]() |
The 2012 Update of the Beers Criteria for Potentially I...
April 1, 2012 - Clinical , In the News / Politics By: Shannon Tellier – Medication related problems can be reduced in older adults if the Beers Criteria were utilized by health care professionals. The criteria serves as a guideline to identify potentially inappropriate medications (PIMs) that should be avoided in the elderly population, but it should not replace clinical judgment. This 2012 update includes a… |
![]() |
HMG-CoA Reductase Inhibitors And Memory Loss...
April 1, 2012 - Clinical , Featured By: Yufan (Frank) Liu, Pharm.D. Candidate c/o 2013 – Results of numerous epidemiological studies have indicated that having high serum cholesterol can lead to coronary heart disease (CHD). 1 More specifically having high LDL cholesterol puts patients at risk for angina and heart attack.2 To reduce this risk HMG-CoA reductase inhibitors, also known as statins,… |
![]() |
Student Pharmacist Star of the Month: Praneeta Nagraj...
March 1, 2012 - Professional Advice / Opinions By: Marie Huang – Each month, the Rho Chi Post has the wonderful opportunity to sit down with an inspiring leader among the student pharmacists here at St. John’s University College of Pharmacy and Allied Health Professions – someone who is not afraid to stand apart from the crowd and can be the change he… |
![]() |
CHF, a Rare but Serious Presentation of Graves’ disea...
March 1, 2012 - Clinical , Featured By: James Schurr, Pharm.D. Candidate c/o 2014 – Graves’ disease is an autoimmune disorder that results in a state of thyrotoxicosis, or a cause of hyperthyroidism, due to the Immunoglobulin G-mediated agonism of thyroid stimulating hormone (TSH) receptors located on the thyroid. Stimulation of TSH receptors causes an increase in circulating thyroxine (T4) and triiodothyronine… |
![]() |
My Residency, My Experience, A Foundation for My Career...
February 1, 2012 - Professional Advice / Opinions By: Sum Lam, PharmD, CGP, BCPS, FASCP – Sum Lam, Pharm.D., CGP, BCPS, FASCP is an Associate Clinical Professor in the Department of Clinical Pharmacy Practice at St. John’s University College of Pharmacy and Allied Health Professions. In conjunction with her full time appointment at St. John’s University, she is a clinical faculty at Geriatric… |
![]() |
Express, Be Involved, and Grow...
February 1, 2012 - Professional Advice / Opinions By: Dr. Gregory J. Hughes – Gregory J. Hughes, PharmD, BCPS, CGP is an Assistant Clinical Professor in the Clinical Pharmacy Practice department at St. John’s University College of Pharmacy and Allied Health Professions. He completed his pharmacy practice residency at the St. Louis VA Medical Center and the St. Louis College of Pharmacy with… |
![]() |
A Message from the New Rho Chi President...
February 1, 2012 - Featured , Professional Advice / Opinions By: Yining Shao – Greetings fellow Rho Chi members and fellow pharmacy candidates! In thinking about my presidency, the following comes to mind: “Leadership and learning are indispensable to each other.” This quote, first stated by John F. Kennedy, remains true today. To be a good leader is not to simply dictate, but rather to… |
![]() |
FDA Approves Edarbyclor®...
January 1, 2012 - Clinical , In the News / Politics By: Gokul Kalla, Pharm.D. Candidate c/o 2013 – Hypertension is a chronic disease that affects one out of every three Americans. Leaving the condition untreated could increase the risk of serious health consequences such as a stroke or a heart attack. On December 21, the FDA approved Takeda Pharmaceuticals’ Edarbyclor® (azilsartan medoxomil and chlorthalidone) for… |
![]() |
Clevidipine in the Management of Hypertensive Emergency...
January 1, 2012 - Clinical , Featured By: Neal Shah – Defined by the Joint National Committee, hypertension (HTN) is a systolic blood pressure (SBP) greater than or equal to 140 mmHg and a diastolic blood pressure (DBP) greater than or equal to 90 mmHg. Patients with Stage 1 HTN have a SBP between 140 and 159 mmHg and DBP between 90… |
![]() |
A Day in the Life of a Cardiac Care Unit Pharmacist...
December 1, 2011 - Professional Advice / Opinions By: Dr. Manouchkathe Cassagnol – Dr. Manouchkathe Cassagnol is an Assistant Clinical Professor at St. John’s University College of Pharmacy and Allied Health Professions and a Clinical Coordinator of Internal Medicine and Cardiology Pharmacotherapy at Long Island Jewish Medical Center. About 81 million people in this country suffer from cardiovascular disease. Therefore, as pharmacy practitioners,… |
![]() |
Differences Between Antagonists and Inverse Agonists...
December 1, 2011 - Clinical By: Neal Shah – There are two major classifications of drug-receptor activity: agonism and antagonism. Agonism occurs when a molecule binds to a receptor, causes an exertion of normal receptor operation, and eventually causes a response. Antagonism of a receptor occurs when a molecule binds to the receptor and does not allow activity to occur.1… |
![]() |
Ivabradine: A Novel I(f) Blocker for Stable Angina...
December 1, 2011 - Clinical By: Neal Shah – Part I: Preface. Part II: Brief review of cardiac electrophysiology. Part III: Ivabradine as a novel If blocker for the use of stable angina. Part IV: On the horizon: trimetazidine. – PREFACE When viewed anatomically, the heart may seem like a simple organ. However, the electrophysiological aspects of the heart are… |
![]() |
Pharmacogenetic Applications in Clinical Practice...
November 1, 2011 - Clinical , Featured By: Neal Shah – The focus of pharmacy is rapidly shifting from simple filling and dispensing of prescriptions to preventative medicine and efficient clinical practice. The field of genetics has been incorporated in many defining therapies and will continue to shape how we treat our patients. Examples discussed here are the roles of human leukocyte… |
![]() |
Clinical Update: Heart Failure and Osteoporosis-Related...
October 1, 2011 - Clinical , Featured By: Mahdieh Danesh Yazdi – Heart failure is a condition in which the heart cannot pump blood efficiently to adequately perfuse tissues. It is often associated with serious consequences, such as kidney failure, liver dam-age, heart attack, and stroke. Patient care is focused on preventing these complications. Recently, attention has turned to other concerns: studies… |